MALIGNANT MESOTHELIOMA

Clinical trials for MALIGNANT MESOTHELIOMA explained in plain language.

Never miss a new study

Get alerted when new MALIGNANT MESOTHELIOMA trials appear

Sign up with your email to follow new studies for MALIGNANT MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 1 Completed 3 Terminated 1

New drug targets genetic weakness in mesothelioma tumors

Disease control Not yet recruiting

This phase 2 trial tests a drug called BMS-986504 in 30 people with relapsed mesothelioma whose tumors have a specific genetic marker (MTAP deficiency). The drug aims to shrink tumors by blocking a protein cancer cells need to grow. Researchers will measure how many patients have…

Matched conditions: MALIGNANT MESOTHELIOMA

Phase: PHASE2 • Sponsor: University of Southampton • Aim: Disease control

Last updated Jun 27, 2026 12:36 UTC

MALIGNANT MESOTHELIOMA

Get alerted when new MALIGNANT MESOTHELIOMA trials appear

New drug targets genetic weakness in mesothelioma tumors